Arich Enterprise Co., Ltd. (TPEX:4173)
24.65
+0.15 (0.61%)
Sep 17, 2025, 1:30 PM CST
Arich Enterprise Revenue
Arich Enterprise had revenue of 378.71M TWD in the quarter ending June 30, 2025, with 19.36% growth. This brings the company's revenue in the last twelve months to 1.44B, up 18.87% year-over-year. In the year 2024, Arich Enterprise had annual revenue of 1.30B with 13.83% growth.
Revenue (ttm)
1.44B
Revenue Growth
+18.87%
P/S Ratio
1.28
Revenue / Employee
7.28M
Employees
198
Market Cap
1.84B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.30B | 157.69M | 13.83% |
Dec 31, 2023 | 1.14B | 122.06M | 11.99% |
Dec 31, 2022 | 1.02B | 72.36M | 7.65% |
Dec 31, 2021 | 945.66M | -305.73M | -24.43% |
Dec 31, 2020 | 1.25B | 139.25M | 12.52% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Lumosa Therapeutics | 37.25M |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Center Laboratories | 1.60B |